254 related articles for article (PubMed ID: 34121311)
1. RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss.
Hu Y; Li X; Zhi X; Cong W; Huang B; Chen H; Wang Y; Li Y; Wang L; Fang C; Guo J; Liu Y; Cui J; Cao L; Weng W; Zhou Q; Wang S; Chen X; Su J
EMBO Rep; 2021 Jul; 22(7):e52481. PubMed ID: 34121311
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss.
Yu W; Zhong L; Yao L; Wei Y; Gui T; Li Z; Kim H; Holdreith N; Jiang X; Tong W; Dyment N; Liu XS; Yang S; Choi Y; Ahn J; Qin L
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33206630
[TBL] [Abstract][Full Text] [Related]
3. RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice.
Fujiwara Y; Piemontese M; Liu Y; Thostenson JD; Xiong J; O'Brien CA
J Biol Chem; 2016 Nov; 291(48):24838-24850. PubMed ID: 27733688
[TBL] [Abstract][Full Text] [Related]
4. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
Dela Cruz A; Grynpas MD; Mitchell J
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
[TBL] [Abstract][Full Text] [Related]
5. [Effect of lipopolysaccharide on osteoclasts formation and bone resorption function and its mechanism].
Zeng L; Xu Y; Xing G
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 May; 32(5):568-574. PubMed ID: 29806344
[TBL] [Abstract][Full Text] [Related]
6. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
7. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption.
Zheng H; Yu X; Collin-Osdoby P; Osdoby P
J Biol Chem; 2006 Jun; 281(23):15809-20. PubMed ID: 16613848
[TBL] [Abstract][Full Text] [Related]
8. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
9. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
10. GATA4 represses RANKL in osteoblasts via multiple long-range enhancers to regulate osteoclast differentiation.
Khalid AB; Slayden AV; Kumpati J; Perry CD; Berryhill SB; Crawford JA; Fatima I; Morselli M; Pellegrini M; Miranda-Carboni GA; Krum SA
Bone; 2018 Nov; 116():78-86. PubMed ID: 30031905
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
12. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow Adipoq-lineage progenitors are a major cellular source of M-CSF that dominates bone marrow macrophage development, osteoclastogenesis, and bone mass.
Inoue K; Qin Y; Xia Y; Han J; Yuan R; Sun J; Xu R; Jiang JX; Greenblatt MB; Zhao B
Elife; 2023 Feb; 12():. PubMed ID: 36779851
[TBL] [Abstract][Full Text] [Related]
14. Hdac3 regulates bone modeling by suppressing osteoclast responsiveness to RANKL.
Molstad DHH; Mattson AM; Begun DL; Westendorf JJ; Bradley EW
J Biol Chem; 2020 Dec; 295(51):17713-17723. PubMed ID: 33454009
[TBL] [Abstract][Full Text] [Related]
15. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
16. Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.
Garimella MG; Kour S; Piprode V; Mittal M; Kumar A; Rani L; Pote ST; Mishra GC; Chattopadhyay N; Wani MR
J Immunol; 2015 Dec; 195(11):5136-48. PubMed ID: 26538398
[TBL] [Abstract][Full Text] [Related]
17. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
18. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
[TBL] [Abstract][Full Text] [Related]
19. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
20. Water extract of the fruits of Alpinia oxyphylla inhibits osteoclast differentiation and bone loss.
Ha H; Shim KS; Kim T; Lee CJ; Park JH; Kim HS; Ma JY
BMC Complement Altern Med; 2014 Sep; 14():352. PubMed ID: 25249312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]